Search research articles
Contact Us
Filters
Showing results (1321-1330 of 1,365) with videos related to
Page
of 137
Sort By:
Future Oncology (London, England)
|
June 27, 2025
NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer
Lior Z Braunstein, Melissa P Mitchell, Hanna Bandos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2022
Phase II Study of Copanlisib in Patients With Tumors With <i>PIK3CA</i> Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F
Senthil Damodaran, Fengmin Zhao, Dustin A Deming, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2018
Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling
Thai H Tran, Fransiscus E Utama, Takahiro Sato, et al.
Medical Physics
|
December 19, 2024
An automated treatment planning portfolio for whole breast radiotherapy
Hana Baroudi, Leonard Che Fru, Deborah Schofield, et al.
Practical Radiation Oncology
|
December 3, 2019
Patterns of Failure Observed in the 2-Step Institution Credentialing Process for NRG Oncology/Radiation Therapy Oncology Group 1005 (NCT01349322) and Lessons Learned
X Allen Li, Jennifer Moughan, Julia R White, et al.
BMJ Supportive & Palliative Care
|
June 6, 2024
Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic
Minsoo Kim, Jose Alberto Maldonado, Prasamsa Pandey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2020
Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i> Mutations: Results of the NCI-MATCH Trial Subprotocol H
April K S Salama, Shuli Li, Erin R Macrae, et al.
JAMA Oncology
|
December 30, 2020
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial
Kevin Kalinsky, Fangxin Hong, Carolyn K McCourt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 11, 2019
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q
K L Jhaveri, X V Wang, V Makker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2020
Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)
Douglas B Johnson, Fengmin Zhao, Marcus Noel, et al.
Page
of 137
Search research articles
Search
Showing results (1321-1330 of 1,365) with videos related to
Sort By:
Page
of 137
Future Oncology (London, England)
|
June 27, 2025
NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer
Lior Z Braunstein, Melissa P Mitchell, Hanna Bandos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2022
Phase II Study of Copanlisib in Patients With Tumors With <i>PIK3CA</i> Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F
Senthil Damodaran, Fengmin Zhao, Dustin A Deming, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2018
Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling
Thai H Tran, Fransiscus E Utama, Takahiro Sato, et al.
Medical Physics
|
December 19, 2024
An automated treatment planning portfolio for whole breast radiotherapy
Hana Baroudi, Leonard Che Fru, Deborah Schofield, et al.
Practical Radiation Oncology
|
December 3, 2019
Patterns of Failure Observed in the 2-Step Institution Credentialing Process for NRG Oncology/Radiation Therapy Oncology Group 1005 (NCT01349322) and Lessons Learned
X Allen Li, Jennifer Moughan, Julia R White, et al.
BMJ Supportive & Palliative Care
|
June 6, 2024
Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic
Minsoo Kim, Jose Alberto Maldonado, Prasamsa Pandey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2020
Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i> Mutations: Results of the NCI-MATCH Trial Subprotocol H
April K S Salama, Shuli Li, Erin R Macrae, et al.
JAMA Oncology
|
December 30, 2020
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial
Kevin Kalinsky, Fangxin Hong, Carolyn K McCourt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 11, 2019
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q
K L Jhaveri, X V Wang, V Makker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2020
Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)
Douglas B Johnson, Fengmin Zhao, Marcus Noel, et al.
Page
of 137